18 results
PRE 14A
GOSS
Gossamer Bio Inc
17 Apr 23
Preliminary proxy
4:01pm
, portfolio sustainability, business development and financial targets. The board of directors, upon recommendation of the compensation committee, determines … and parity in targets among executives in roles of a given level. For 2022, our compensation committee reviewed competitive market data prepared
8-K
EX-99.2
5qkrqqrxq3awc
14 May 19
Gossamer Bio Announces First Quarter 2019 Financial Results
7:31am
424B4
z8vnq5
8 Feb 19
Prospectus supplement with pricing info
4:40pm
S-1/A
080o6
23 Jan 19
IPO registration (amended)
4:39pm
S-1
EX-10.8
ourc6b 8k
21 Dec 18
IPO registration
4:39pm
S-1
99cntd40
21 Dec 18
IPO registration
4:39pm
S-1
EX-10.1
qbfkou0q wkudvfu
21 Dec 18
IPO registration
4:39pm
S-1
EX-10.9
wdi3yitz09zrecu jt
21 Dec 18
IPO registration
4:39pm
DRS/A
tbmvi7ig
29 Nov 18
Draft registration statement (amended)
12:00am
DRS
EX-10.8
5rdsoqd3g h1
11 Oct 18
Draft registration statement
12:00am
DRS
3b902j3959byonfsa
11 Oct 18
Draft registration statement
12:00am
DRS
EX-10.9
bt0alv0ct4t 892hioo
11 Oct 18
Draft registration statement
12:00am
DRS
EX-10.1
j11h7e
11 Oct 18
Draft registration statement
12:00am
- Prev
- 1
- Next